CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · IEX Real-Time Price · USD
0.370
-0.005 (-1.33%)
At close: Mar 27, 2024, 4:00 PM
0.388
+0.018 (4.89%)
Pre-market: Mar 28, 2024, 8:41 AM EDT

CNS Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Net Income
-15.27-14.5-9.46-3.88-7.39
Depreciation & Amortization
0.010.010.0100
Share-Based Compensation
1.21.721.290.630.11
Other Operating Activities
3.5-0.780.84-0.316.57
Operating Cash Flow
-10.56-13.54-7.32-3.55-0.72
Capital Expenditures
-0-0.01-0.02-0.020
Investing Cash Flow
-0-0.01-0.02-0.020
Share Issuance / Repurchase
16.044.9914.2210.290.39
Debt Issued / Paid
-0.43-0.48-0.04-0.040.3
Other Financing Activities
---0.05-0.47
Financing Cash Flow
15.614.5114.1310.261.16
Net Cash Flow
5.05-9.036.86.690.44
Free Cash Flow
-10.56-13.54-7.34-3.57-0.72
Free Cash Flow Per Share
-7.76-15.42-13.24-7.86-2.04
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).